Arkolith/Insider Trading/BTX/Form 4

Cherington Charles

Director, 10% OwnerBrooklyn ImmunoTherapeutics, Inc. (BTX) · full profile →Form 4 · filed Jun 21, 2021
Net Selling
Open-Market Buys
$0
Open-Market Sells
$6.3M
Net Open-Market Flow
-$6.3M
Transactions
3
3 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jun 17, 2021Sell(S)2K$16.30$33K5.9M
Jun 17, 2021Sell(S)198K$15.74$3.1M5.9M
Jun 16, 2021Sell(S)200K$15.73$3.1M6.1M

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001140361-21-021772) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML